Cargando…
CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPKα2 and enhancing nuclear translocation of Akt1
Cytochrome P450 epoyxgenase 2J2 and epoxyeicosatrienoic acids (EETs) are known to protect against cardiac hypertrophy and heart failure, which involve the activation of 5′‐AMP‐activated protein kinase (AMPK) and Akt. Although the functional roles of AMPK and Akt are well established, the significanc...
Autores principales: | Wang, Bei, Zeng, Hesong, Wen, Zheng, Chen, Chen, Wang, Dao Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013012/ https://www.ncbi.nlm.nih.gov/pubmed/27416746 http://dx.doi.org/10.1111/acel.12507 |
Ejemplares similares
-
CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators
por: Shi, Zeqi, et al.
Publicado: (2022) -
Higher Epoxyeicosatrienoic Acids in Cardiomyocytes-Specific CYP2J2 Transgenic Mice Are Associated with Improved Myocardial Remodeling
por: Aliwarga, Theresa, et al.
Publicado: (2020) -
CYP2J2 and Its Metabolites EETs Attenuate Insulin Resistance via Regulating Macrophage Polarization in Adipose Tissue
por: Dai, Meiyan, et al.
Publicado: (2017) -
CYP2C19 variants and epoxyeicosatrienoic acids in patients with microvascular angina
por: Akasaka, Tomonori, et al.
Publicado: (2017) -
A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity
por: LIU, WANJUN, et al.
Publicado: (2014)